Richard D Francis sold $10.6M of TEVA stock

Richard D Francis, President and CEO of Teva Pharmaceutical Industries Ltd (TEVA), sold 250,000 shares of TEVA stock worth $10.6M, per an SEC Form 4 filed Nov 12, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 10, 2026, 2 days before it was made public.

TEVA has moved +2.9% since the trade date, from $42.40 to $43.65 (Nov 12, 2026 close).